Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma
Saved in:
| Published in | Blood Vol. 140; no. Supplement 1; pp. 4586 - 4587 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Elsevier Inc
15.11.2022
|
| Online Access | Get full text |
| ISSN | 0006-4971 1528-0020 |
| DOI | 10.1182/blood-2022-166994 |
Cover
| Author | Ly, Thomas Valamehr, Bahram Gregory, Tara Byon, John Wong, Lilly Bickers, Cara Cooley, Sarah Abonour, Rafat Dhakal, Binod Goodridge, Jode P. Chu, Yu-Waye Berdeja, Jesus G. Zong, Xingyue |
|---|---|
| Author_xml | – sequence: 1 givenname: Binod surname: Dhakal fullname: Dhakal, Binod organization: Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI – sequence: 2 givenname: Jesus G. surname: Berdeja fullname: Berdeja, Jesus G. organization: Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN – sequence: 3 givenname: Tara surname: Gregory fullname: Gregory, Tara organization: Colorado Blood Cancer Institute, Sarah Cannon Cancer Network, Denver, CO – sequence: 4 givenname: Thomas surname: Ly fullname: Ly, Thomas organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 5 givenname: Cara surname: Bickers fullname: Bickers, Cara organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 6 givenname: Xingyue surname: Zong fullname: Zong, Xingyue organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 7 givenname: Lilly surname: Wong fullname: Wong, Lilly organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 8 givenname: Jode P. surname: Goodridge fullname: Goodridge, Jode P. organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 9 givenname: Sarah surname: Cooley fullname: Cooley, Sarah organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 10 givenname: Bahram surname: Valamehr fullname: Valamehr, Bahram organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 11 givenname: Yu-Waye surname: Chu fullname: Chu, Yu-Waye organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 12 givenname: John surname: Byon fullname: Byon, John organization: Fate Therapeutics, Inc., San Diego, CA – sequence: 13 givenname: Rafat surname: Abonour fullname: Abonour, Rafat organization: Indiana University School of Medicine, Indianapolis, IN |
| BookMark | eNp9kMtOwzAQRS0EEuXxAez8AwHbcV5ihcqrEhUIyjqa2BPVlWNXtgvqV_DLpJQVC1azuHOudM8JOXTeISEXnF1yXourznqvM8GEyHhZNo08IBNeiDpjTLBDMmGMlZlsKn5MTmJcMcZlLooJ-Zq5hMEM9GUJEemMTq1xRoGlt5CA-p7eL4qqpDeRzr3zaYkB1lsKTlPj6NQPnXGQjHf006TlCAVIm2EzQLfL3zbdClWK-_AVLawj6qtX7AOo5MOWzjc2mbVFOt-i9QOckaMebMTz33tK3u_vFtPH7On5YTa9ecoUl0JmWkjW5bVkec20qnXPu67peCG1rrkqQeUARTV-NFWjCsi17qHEQgrOtey5zk8J3_eq4GMM2Lfr0QKEbctZuzPa_hhtd0bbvdGRqf4wyqSf8SmAsf-S13sSx0kfBkMblUGnUJsw-mm1N__Q38QYlHk |
| CitedBy_id | crossref_primary_10_1200_OP_24_00752 crossref_primary_10_3389_fimmu_2024_1414264 crossref_primary_10_1016_j_stem_2024_06_009 crossref_primary_10_1515_mr_2023_0031 crossref_primary_10_1038_s41408_024_01191_8 crossref_primary_10_3390_biology12111419 crossref_primary_10_1093_lifemedi_lnaf002 crossref_primary_10_1016_j_ymthe_2024_01_027 crossref_primary_10_1080_17474086_2024_2370552 crossref_primary_10_3389_fimmu_2024_1356666 crossref_primary_10_1186_s12943_023_01885_w crossref_primary_10_1111_ejh_14051 crossref_primary_10_1038_s41392_023_01521_5 crossref_primary_10_1016_j_omton_2024_200885 crossref_primary_10_3390_cancers16223867 crossref_primary_10_3389_fcell_2024_1491282 crossref_primary_10_3389_fonc_2023_1275076 crossref_primary_10_1182_bloodadvances_2023010856 crossref_primary_10_1016_j_heliyon_2024_e27892 crossref_primary_10_1016_j_tibtech_2024_07_012 crossref_primary_10_3390_cells13231976 crossref_primary_10_1002_cpt_3241 crossref_primary_10_3389_fimmu_2024_1459818 crossref_primary_10_1016_j_prp_2024_155518 crossref_primary_10_1186_s13045_023_01435_3 |
| ContentType | Journal Article |
| Copyright | 2022 The American Society of Hematology |
| Copyright_xml | – notice: 2022 The American Society of Hematology |
| DBID | AAYXX CITATION |
| DOI | 10.1182/blood-2022-166994 |
| DatabaseName | CrossRef |
| DatabaseTitle | CrossRef |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Biology Anatomy & Physiology |
| EISSN | 1528-0020 |
| EndPage | 4587 |
| ExternalDocumentID | 10_1182_blood_2022_166994 S0006497122035558 |
| GroupedDBID | --- -~X .55 1CY 23N 2WC 34G 39C 4.4 53G 5GY 5RE 5VS 6J9 AAEDW AAXUO ABOCM ABVKL ACGFO ADBBV AENEX AFOSN ALMA_UNASSIGNED_HOLDINGS AMRAJ BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD EX3 F5P FDB FRP GS5 GX1 IH2 K-O KQ8 L7B LSO MJL N9A OK1 P2P R.V RHF RHI ROL SJN THE TR2 TWZ W2D W8F WH7 WOQ WOW X7M YHG YKV ZA5 0R~ AALRI AAYXX ACVFH ADCNI ADVLN AEUPX AFETI AFPUW AGCQF AIGII AITUG AKBMS AKRWK AKYEP CITATION H13 |
| ID | FETCH-LOGICAL-c1424-d240b3840380dc8df1bb9b154dd81c6ac3aa57b38979c5a3ddfa6e54211d4f1d3 |
| ISSN | 0006-4971 |
| IngestDate | Tue Jul 01 04:30:03 EDT 2025 Thu Apr 24 22:52:51 EDT 2025 Fri Feb 23 02:37:07 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Supplement 1 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c1424-d240b3840380dc8df1bb9b154dd81c6ac3aa57b38979c5a3ddfa6e54211d4f1d3 |
| PageCount | 2 |
| ParticipantIDs | crossref_primary_10_1182_blood_2022_166994 crossref_citationtrail_10_1182_blood_2022_166994 elsevier_sciencedirect_doi_10_1182_blood_2022_166994 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-11-15 |
| PublicationDateYYYYMMDD | 2022-11-15 |
| PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationTitle | Blood |
| PublicationYear | 2022 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| SSID | ssj0014325 |
| Score | 2.4102411 |
| SourceID | crossref elsevier |
| SourceType | Enrichment Source Index Database Publisher |
| StartPage | 4586 |
| Title | Interim Phase I Clinical Data of FT576 As Monotherapy and in Combination with Daratumumab in Subjects with Relapsed/Refractory Multiple Myeloma |
| URI | https://dx.doi.org/10.1182/blood-2022-166994 |
| Volume | 140 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9NAFB6FIpYLgpSKlkVzQByI3HoZO84xTQktIogllXqzZjxjNW3iVEl8CH-CH8Cf5b1ZErcEBL1Y9oyXkb7PM-_N2wh5DZArznzm4aaCxyLOPO5H3ANlSAkhJe9ob_fBp-T4lH04i88ajZ81r6VqIfbz7xvjSm6DKrQBrhgl-x_Irl4KDXAO-MIREIbjP2Gst_NGk9bnc1iLWietngtzPOILjmJgfwiCPkCAv64NtXL5lnAmAK3Y4K93Y48wC3g1qSZcYD9MKRfa1UN3otPc1Rx3RvtfVTHTVXqWrYFzRxws1Xhqp3hnIh7bOvRaTj7nl9wYOEbluvlQzaS6MO66al7NW-_3aw5BGDyj-cRnq8Xj4_KGW5PdsQBlF73m4vU2mguluebpiesmlrszRFN2Nsb02X7oX5uuTXonO-Gy2GXSdpftzQtDiolmTTCAGVOSdEx55Rv5tr9pMQ0GEoZ-hNnQ7pC7YRsEM7T4f1mbqFgUmvIYdtzWZA4fOvjtM5uFnpogM3xMHlkNhHYNnZ6QhiqbZLsLTJhOlvQN1T7B2tjSJPcO3dmDnqsM2CT3B9YhY5v8sBSkmoL0hDoKUqQgnRZUU5B257RGQQoUpKOS1ihIkWW0RkHsdxQ0nY6CB2sCUkdAagn4lJz23w17x56t8eHlGGPpSZAoRZQyP0p9maeyCIToCJDrpUyDPOF5xHnchjs67U4e80jKgicqZmEQSFYEMtohW-W0VM8ILRiatFnRDuClTCjuB0UCGnuKpWSCpNglvgMhy20CfKzDMs60IpyGmcYtQ9wyg9suebt65Mpkf_nbzcwhm1nx1YilGZDwz4_t3e6x5-Th-t96QbYWs0q9BPl4IV5pnv4CAAO5VQ |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Interim+Phase+I+Clinical+Data+of+FT576+As+Monotherapy+and+in+Combination+with+Daratumumab+in+Subjects+with+Relapsed%2FRefractory+Multiple+Myeloma&rft.jtitle=Blood&rft.au=Dhakal%2C+Binod&rft.au=Berdeja%2C+Jesus+G.&rft.au=Gregory%2C+Tara&rft.au=Ly%2C+Thomas&rft.date=2022-11-15&rft.pub=Elsevier+Inc&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=140&rft.spage=4586&rft.epage=4587&rft_id=info:doi/10.1182%2Fblood-2022-166994&rft.externalDocID=S0006497122035558 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon |